1. Home
  2. SLRX vs FTAIM Comparison

SLRX vs FTAIM Comparison

Compare SLRX & FTAIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • FTAIM
  • Stock Information
  • Founded
  • SLRX N/A
  • FTAIM N/A
  • Country
  • SLRX United States
  • FTAIM United States
  • Employees
  • SLRX N/A
  • FTAIM 580
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • FTAIM Misc Corporate Leasing Services
  • Sector
  • SLRX Health Care
  • FTAIM Industrials
  • Exchange
  • SLRX Nasdaq
  • FTAIM Nasdaq
  • Market Cap
  • SLRX 1.8M
  • FTAIM N/A
  • IPO Year
  • SLRX N/A
  • FTAIM N/A
  • Fundamental
  • Price
  • SLRX $0.89
  • FTAIM $26.75
  • Analyst Decision
  • SLRX
  • FTAIM
  • Analyst Count
  • SLRX 0
  • FTAIM 0
  • Target Price
  • SLRX N/A
  • FTAIM N/A
  • AVG Volume (30 Days)
  • SLRX 3.5M
  • FTAIM N/A
  • Earning Date
  • SLRX 08-08-2025
  • FTAIM N/A
  • Dividend Yield
  • SLRX N/A
  • FTAIM N/A
  • EPS Growth
  • SLRX N/A
  • FTAIM N/A
  • EPS
  • SLRX N/A
  • FTAIM N/A
  • Revenue
  • SLRX N/A
  • FTAIM N/A
  • Revenue This Year
  • SLRX N/A
  • FTAIM N/A
  • Revenue Next Year
  • SLRX N/A
  • FTAIM N/A
  • P/E Ratio
  • SLRX N/A
  • FTAIM N/A
  • Revenue Growth
  • SLRX N/A
  • FTAIM N/A
  • 52 Week Low
  • SLRX $0.45
  • FTAIM N/A
  • 52 Week High
  • SLRX $7.20
  • FTAIM N/A
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 49.87
  • FTAIM 53.95
  • Support Level
  • SLRX $0.86
  • FTAIM $26.60
  • Resistance Level
  • SLRX $1.33
  • FTAIM $26.93
  • Average True Range (ATR)
  • SLRX 0.14
  • FTAIM 0.14
  • MACD
  • SLRX -0.01
  • FTAIM -0.02
  • Stochastic Oscillator
  • SLRX 38.74
  • FTAIM 45.45

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares

FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.

Share on Social Networks: